Author

Punam Malik

Professor of Pediatrics - Cited by 6,805

Biography

Dr Punam Malik is being a Director in the Cincinnati Comprehensive Sickle Cell Center and Program Leader, Hematology and Gene Therapy Program. She is working as a Professor in the UC Department of Pediatrics.
Title
Cited by
Year
Therapeutic strategies for sickle cell disease: towards a multi-agent approach
MJ Telen, P Malik, GM VercellottiNature Reviews Drug Discovery 18 (2), 139-158, 2019201
141
2019
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
R Jayavaradhan, DM Pillis, M Goodman, F Zhang, Y Zhang, ...Nature communications 10 (1), 2866, 2019201
120
2019
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
O Niss, R Fleck, F Makue, T Alsaied, P Desai, JA Towbin, P Malik, ...Blood 130 (2), 205-213, 2017201
87
2017
Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives
K Daily, SJH Sui, LM Schriml, PJ Dexheimer, N Salomonis, R Schroll, ...Scientific data 4, 170030, 2017201
56
2017
Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children with Sickle Cell Anemia
PT McGann, O Niss, M Dong, A Marahatta, T Howard, T Mizuno, A Lane, ...American journal of hematology, 2019201
52
2019
p190-B RhoGAP and intracellular cytokine signals balance hematopoietic stem and progenitor cell self-renewal and differentiation
A Hinge, J Xu, J Javier, E Mose, S Kumar, R Kapur, EF Srour, P Malik, ...Nature communications 8, 14382, 2017201
40
2017
Losartan for the nephropathy of sickle cell anemia: A phase‐2, multicenter trial
CT Quinn, SL Saraf, VR Gordeuk, CD Fitzhugh, SE Creary, P Bodas, ...American journal of hematology 92 (9), E520-E528, 2017201
38
2017
Gene therapy for sickle cell anemia using a modified gamma globin lentivirus vector and reduced intensity conditioning transplant shows promising correction of the disease …
P Malik, M Grimley, CT Quinn, A Shova, L Courtney, C Lutzko, TA Kalfa, ...Blood 132 (Suppl 1), 1021-1021, 2018201
27
2018
Patient perspectives on gene transfer therapy for sickle cell disease
H Strong, MJ Mitchell, A Goldstein-Leever, L Shook, P Malik, LE CrosbyAdvances in therapy 34 (8), 2007-2021, 2017201
23
2017
KIT blockade is sufficient for donor hematopoietic stem cell engraftment in Fanconi anemia mice
S Chandrakasan, R Jayavaradhan, J Ernst, A Shrestha, A Loberg, ...Blood 129 (8), 1048-1052, 2017201
22
2017
A versatile tool for the quantification of CRISPR/Cas9-induced genome editing events in human hematopoietic cell lines and hematopoietic stem/progenitor cells
R Jayavaradhan, DM Pillis, P MalikJournal of molecular biology 431 (1), 102-110, 2019201
17
2019
Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia
M Nasimuzzaman, PI Arumugam, ES Mullins, JM James, ...Blood advances 3 (9), 1519-1532, 2019201
17
2019
Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia
T Alsaied, O Niss, AW Powell, RJ Fleck, JF Cnota, C Chin, P Malik, ...Pediatric blood & cancer 65 (8), e27113, 2018201
17
2018
Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy
S Roy, P Rai, MSEM Mpollo, KH Chang, T Rizvi, SK Shanmukhappa, ...American journal of hematology 93 (7), E7, 2018201
17
2018
CRISPR/Cas9 in allergic and immunologic diseases
MA Goodman, D Moradi Manesh, P Malik, ME RothenbergExpert review of clinical immunology 13 (1), 5-9, 202
17
2017
Placenta growth factor mediated gene regulation in sickle cell disease
VK Kalra, S Zhang, P Malik, SM TaharaBlood reviews 32 (1), 61-70, 2018201
13
2018
A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia
P Rai, O Niss, P MalikPediatric blood & cancer 64 (11), e26607, 2017201
13
2017
Foamy virus vector carries a strong insulator in its long terminal repeat which reduces its genotoxic potential
MA Goodman, P Arumugam, DM Pillis, A Loberg, M Nasimuzzaman, ...Journal of virology 92 (1), e01639-17, 2018201
12
2018
Production and Purification of Baculovirus for Gene Therapy Application
M Nasimuzzaman, JCM van der Loo, P MalikJoVE (Journal of Visualized Experiments), e57019, 2018201
11
2018
Genetic therapies for sickle cell disease
R Jayavaradhan, P MalikPediatric Clinics 65 (3), 465-480, 2018201
9
2018

Referred From: https://scholar.google.com/citations?user=etDzeEEAAAAJ&hl=en

Cited by
Citations 6805
h-index 46
i10-index 92
Recommended Journals
Open Access Journals